Develops, manufactures and markets a robust line of rapid diagnostic tests that address some of today's greatest healthcare challenges, including HIV and Hepatitis C.

Free
Message: volume

Re: volume

in response to by
posted on May 08, 2008 09:27PM

I am still trying to get a feel for how this one trades, but there is talk that the financing has been completed, these kinds of deals, private placements, with any company always seem to set share prices back while the deal is put together. Then again these are good times for small investors to purchase a few cheap shares, and then it next should move up.

Dimar

Share
New Message
Please login to post a reply